Asthma Clinical Trial
Official title:
Randomized Controlled Trial of Spirometry Fundamentals™ in the Primary Care Setting
Spirometry is a recommended component of asthma diagnosis and treatment in the primary care
setting, yet few primary care providers report routine use of spirometry in the provision of
care for their asthma patients. Misclassification of asthma severity has been reported when
assessment is based on symptoms alone. This misclassification can lead to inadequate
treatment that may result in increased morbidity and increased healthcare utilization/cost.
However, even when spirometry is utilized to aid in asthma severity classification, primary
care providers have a high rate of failing to meet the quality goals for testing established
by the American Thoracic Society.
The goal of this study is to evaluate the effectiveness of the Spirometry Fundamentals™ tool
in training primary care providers and their staff in producing high-quality flow-volume
curves as compared to existing training modalities and to gather information in a
'real-world' setting that can be used to improve Spirometry Fundamentals™.
Currently few self-paced, distance learning programs exist that train staff to perform good
quality spirometry tests. This study evaluates the effectiveness of a distance-learning tool
for training primary care providers and their medical assistants in the use of spirometry to
assist in managing obstructive lung disease (asthma and COPD). This tool is called
"Spirometry Fundamentals™: A basic guide to lung function testing". It is a computer-based
training program that teaches primary care providers and their staff what spirometry is, how
it can be used, the techniques required to perform high-quality spirometry, and clinical
interpretation of the spirometric data.
We evaluated the effectiveness of Spirometry Fundamentals in the primary care setting by
conducting a randomized controlled trial (RCT). Study participants were primary care
physicians (MDs or DOs) and their staff (medical assistants (MAs) or nurses (RNs)) and were
recruited as study pairs. The role of the MDs was to utilize spirometry in clinical care by
ordering spirometry tests based on their clinical judgment, and the role of the MAs was to
perform the spirometry. The patients performed the spirometry as part of their usual care
were not considered study subjects.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|